QA: GENOMIC HEALTH INC in us_health_services/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001131324_2019_GENOMIC_HEALTH_INC.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.2094381642008752, 'aggregate_val': 371462000, 'exp_sum': 307136000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 76910000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 0, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 164779000, 'ResearchAndDevelopmentExpense': 64200000, 'remainder_Expenses': 1247000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001131324')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001131324, GENOMIC HEALTH INC

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 15,938,000
2 AssetsCurrent 274,836,000
3 PropertyPlantAndEquipment 39,532,000
4 remainder_Assets 4,066,000
5 LongTermLiabilities 0
6 LiabilitiesCurrent 59,776,000
7 remainder_Liabilities 0
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 0
10 GeneralAndAdministrativeExpense 76,910,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 164,779,000
15 ResearchAndDevelopmentExpense 64,200,000
16 remainder_Expenses 65,573,000
17 remainder_Revenues 394,111,000
18 remainder_NetIncome 3,028,000
19 remainder_ComprehensiveNetIncome 27,000
  yvar yval
0 Assets 334,372,000
1 Liabilities 59,776,000
2 Expenses 371,462,000
3 Revenues 394,111,000
4 StockholdersEquity 274,596,000
5 NetIncome 25,677,000
6 ComprehensiveNetIncome 25,704,000
7 BaseVar 708,211,620
8 EconomicCapitalRatio 2.53

Edgar->Model Mapping

Feature Distribution

Change over Time